Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study.

Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study.

<h4>Background</h4>Fibroblast growth factor 23 is an emerging vascular biomarker, recently associated with cerebral small vessel disease and poor cognition in patients on dialysis. It also interacts with klotho, an anti-aging and cognition enhancing protein.<h4>Objective</h4>...

Full description

Bibliographic Details
Main Authors:	Emer R McGrath, Jayandra J Himali, Daniel Levy, Sarah C Conner, Matthew P Pase, Carmela R Abraham, Paul Courchesne, Claudia L Satizabal, Ramachandran S Vasan, Alexa S Beiser, Sudha Seshadri
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0213321

Similar Items

Identifying Blood Biomarkers for Dementia Using Machine Learning Methods in the Framingham Heart Study
by: Honghuang Lin, et al.
Published: (2022-04-01)

Red Blood Cell DHA Is Inversely Associated with Risk of Incident Alzheimer’s Disease and All-Cause Dementia: Framingham Offspring Study
by: Aleix Sala-Vila, et al.
Published: (2022-06-01)

Cerebral small vessel disease burden is associated with decreased abundance of gut Barnesiella intestinihominis bacterium in the Framingham Heart Study
by: Bernard Fongang, et al.
Published: (2023-08-01)

Relations of Metabolic Health and Obesity to Brain Aging in Young to Middle‐Aged Adults
by: Rebecca Angoff, et al.
Published: (2022-03-01)

Platelet Function Is Associated With Dementia Risk in the Framingham Heart Study
by: Jaime Ramos‐Cejudo, et al.
Published: (2022-05-01)

Integrated omics analysis of coronary artery calcifications and myocardial infarction: the Framingham Heart Study
by: Amalie Lykkemark Møller, et al.
Published: (2023-12-01)

Contribution of the neighborhood environment to cross-sectional variation in long-term CVD risk scores in the Framingham Heart Study.
by: Todd R Sponholtz, et al.
Published: (2018-01-01)

Prevalence, Predictors, Progression, and Prognosis of Hypertension Subtypes in the Framingham Heart Study
by: Maximillian T. Bourdillon, et al.
Published: (2022-03-01)

Temporal Trends in Incidence of Premature Cardiovascular Disease Over the Past 7 Decades: The Framingham Heart Study
by: Ramachandran S. Vasan, et al.
Published: (2022-10-01)

Association of Life's Essential 8 With Cardiovascular Disease and Mortality: The Framingham Heart Study
by: Athanasios Rempakos, et al.
Published: (2023-12-01)

Association of Mildly Reduced Kidney Function With Cardiovascular Disease: The Framingham Heart Study
by: Feven Ataklte, et al.
Published: (2021-08-01)

Correction to: Platelet Function Is Associated With Dementia Risk in the Framingham Heart Study
Published: (2022-09-01)

Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study.
by: Ibrahim Musa Yola, et al.
Published: (2021-01-01)

Proteomic and Metabolomic Correlates of Healthy Dietary Patterns: The Framingham Heart Study
by: Maura E. Walker, et al.
Published: (2020-05-01)

A population‐based meta‐analysis of circulating GFAP for cognition and dementia risk
by: Mitzi M. Gonzales, et al.
Published: (2022-10-01)

Association of Lower Plasma Homoarginine Concentrations with Greater Risk of All-Cause Mortality in the Community: The Framingham Offspring Study
by: Edzard Schwedhelm, et al.
Published: (2020-06-01)

Blood biomarkers for dementia in Hispanic and non‐Hispanic White adults
by: Mitzi M. Gonzales, et al.
Published: (2021-01-01)

Longitudinal Hemodynamic Correlates of and Sex Differences in the Evolution of Blood Pressure Across the Adult Lifespan: The Framingham Heart Study
by: Gary F. Mitchell, et al.
Published: (2023-06-01)

Metabolomic Profiles, Ideal Cardiovascular Health, and Risk of Heart Failure and Atrial Fibrillation: Insights From the Framingham Heart Study
by: Yi Li, et al.
Published: (2023-06-01)

Risks of Incident Cardiovascular Disease Associated With Concomitant Elevations in Lipoprotein(a) and Low‐Density Lipoprotein Cholesterol—The Framingham Heart Study
by: Mehdi Afshar, et al.
Published: (2020-09-01)

Expression quantitative trait methylation analysis elucidates gene regulatory effects of DNA methylation: the Framingham Heart Study
by: Amena Keshawarz, et al.
Published: (2023-08-01)

Framingham risk equations underestimate coronary heart disease risk in diabetes.
by: Stevens, R, et al.
Published: (2005)

Cardiovascular disease protein biomarkers are associated with kidney function: The Framingham Heart Study.
by: Amena Keshawarz, et al.
Published: (2022-01-01)

Population attributable fraction of hypertension for dementia: global, regional, and national estimates for 186 countriesResearch in context
by: Martin D. Mulligan, et al.
Published: (2023-06-01)

Reference distributions of aortic calcification and association with Framingham risk score
by: Steven R. Horbal, et al.
Published: (2023-06-01)

Association of Arterial Stiffness With Mid- to Long-Term Home Blood Pressure Variability in the Electronic Framingham Heart Study: Cohort Study
by: Xuzhi Wang, et al.
Published: (2024-04-01)

Neck Circumference and Risk of Incident Atrial Fibrillation in the Framingham Heart Study
by: Jelena Kornej, et al.
Published: (2022-02-01)

Exploring cognitive progression subtypes in the Framingham Heart Study
by: Huitong Ding, et al.
Published: (2024-01-01)

Yogurt Consumption Is Associated with Lower Levels of Chronic Inflammation in the Framingham Offspring Study
by: Mengjie Yuan, et al.
Published: (2021-02-01)

The fibroblast growth factor system in cognitive disorders and dementia
by: Wujianwen Zhai, et al.
Published: (2023-05-01)

Blood Pressure and Cardiovascular Disease: Tracing the Steps From Framingham
by: Turnbull, F, et al.
Published: (2010)

Recalibration of Framingham risk for a local population of Sri Lanka
by: Sameera Upashantha Ranasinghe, et al.
Published: (2024-01-01)

Establishing cognitive baseline in three generations: Framingham Heart Study
by: Jin Yang, et al.
Published: (2023-01-01)

302 Epicardial fat thickness increases with age, body mass index and male sex: the framingham heart study
by: Manning Anya R, et al.
Published: (2008-10-01)

Evaluating SCORE and Framingham fatal coronary heart disease risk equations using UKPDS data
by: Coleman, R, et al.
Published: (2004)

Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort.
by: Hua, X, et al.
Published: (2017)

Who benefits? how local ethnic demography shapes political favoritism in Africa
by: Beiser-McGrath, J, et al.
Published: (2020)

Characterizing longitudinal change in accelerometry-based moderate-to-vigorous physical activity in the Hispanic Community Health Study/Study of Latinos and the Framingham Heart Study
by: Yasmin Mossavar-Rahmani, et al.
Published: (2023-08-01)

Identifying underweight in infants and children using growth charts, lookup tables and a novel “MAMI” slide chart: A cross-over diagnostic and acceptability study
by: Meenakshi Monga, et al.
Published: (2023-01-01)

Validity of the Framingham point scores in the elderly: results from the Rotterdam study.
by: Koller, M, et al.
Published: (2007)